Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
This webinar presentation will address the critical importance of the
following:
This webinar discusses the five strategies to build a robust CMC package, help streamline the path to FIH trials for biologics and establish the quality foundation needed to support all of the development phases toward commercialization including:
This webinar will provide key advice for determining and navigating the regulatory pathway for any cell and gene therapy, including the following